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Abstract Nitric oxide (NO) is a cell-signaling molecule
that has diverse biological functions. Recent evidence
suggests that its production may regulate the metabolism
of the osteoblasts and osteoclasts. The aim of this study was
to evaluate levels of nitrite and nitrates (NO metabolites)
during ectopic osteoinduction in rats. Eighteen male
Sprague–Dawley rats (body weight 200–300 g) were used
in this study. All animals were anesthetized and the right
and left flank areas were shaved, and under aseptic
conditions, a muscular pouch was created in each flank:
the left was filled with 20 mg of demineralized bone matrix
and the right remained empty (sham). Radiographs were
taken at 2, 4, and 6 weeks after surgery to trace the ectopic
bone formation and muscle mineralization. Blood samples
were taken before (as baseline values) and at 2, 4, and
6 weeks after surgery. The mean values of NO metabolites
after 6 weeks were significantly higher (p<0.05) than
baseline data and at 2 weeks post-surgery. Results from this
study indicate that the ectopic osteoinduction caused
increased activity of the osteoblasts which subsequently
caused increased serum levels of NO metabolites (nitrites
and nitrates).
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Introduction
Bone is known to contain at least two types of cells,
osteoblasts—the bone-forming cells—and osteoclasts—the
bone-resorbing cells. Bone remodeling requires the proper
maintenance and balance of these two types of cells, and
imbalance often leads to pathophysiology. Bone metabolism
is regulated by hormones and cytokines that affect the
resorption and deposition of bone. These processes are
normally coordinated so that deposition is balanced with
resorption of bone (McClung 2003; Lindsay 2004). Proin-
flammatory cytokines, such as tumor necrosis factor-α
(TNF-α) and interferon-γ (IFN-γ), function as potent local
stimulatory signals for bone resorption. These factors interact
with the receptors present on osteoblasts to modulate bone
formation. Osteoclast resorption is modulated by the release
of unknown signals collectively known as the osteoclast
resorption-stimulating activity (Ueno et al. 1998).
Nitric oxide (NO) is a free-radical gas consisting of a very
small lipophilic molecule which rapidly diffuses and reaches
the cytoplasmic components resulting in the activation of
diverse biological functions (Hamed et al. 2006). It has been
implicated as an important gas mediator and secondary
messenger molecule in biological processes involving vaso-
dilatation, inflammation, and neurotransmission. Recent
evidence suggests that its production may regulate the
metabolism of osteoblasts and osteoclasts (Collin-Osdoby et
al. 1995; Corbett et al. 1999; Diwan et al. 2000). NO is now
known to be produced by various cells in different organs,
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including smooth muscle cells, mesenchymal cells, neurons,
platelets, hepatocytes, macrophages, fibroblasts, and epithe-
lial cells. It also regulates smooth muscle cell tone, platelet
aggregation, adhesion, cell growth, apoptosis, neurotrans-
mission, and injuries as well as infection-induced immune
reactions (Lincoln et al. 1997; Pacher et al. 2007). It is
involved in a variety of conditions such as inflammation
(Farrell et al. 1992; Stefanovic-Racic et al. 1994), arthritis
(Farrell et al. 1992; Kaur and Halliwell 1994; Sakurai et al.
1995), osteoporosis (Wimalawansa et al. 1996), sepsis
(Buttery et al. 1994), and aseptic loosening (Hukkanen et
al. 1997).
NO is generated by the conversion of the amino acid
L-arginine to L-citrulline in a reaction catalyzed by a family
of isoenzymes arising from three distinct genes. Two of
these isoenzymes, endothelial NO synthase (eNOS; type
III) and neuronal NOS (nNOS; type I), are thought to
be constitutive in nature. They are calcium-dependent and
generally considered to be involved in physiological homeo-
stasis generating basal levels of NO. The synthesis and
activity of the third isoform, inducible NOS (iNOS; type II),
is induced by many proinflammatory cytokines and are
thought to be calcium-independent (Nathan and Xie 1994;
Garcia and Stein 2006). NO has been shown to have
significant effects on osteoblasts, osteoclasts, and osteo-
cytes. Both eNOS and iNOS have an important role in the
regulation of the proliferation and function of osteoblasts
(Ralston 1994; Hukkanen 1995; Riancho et al. 1995).
Osteoinductive properties of allogenic and xenogenic
demineralized bone matrix (DBM) has been studied previ-
ously (Solheim 1998; Torricelli et al. 1999; Bigham et al.
2008). Demineralized bone-induced heterotopic osteo-
genesis in rodents has been used as an experimental model
to investigate osteoinduction itself as well as to study the
effects of several influences on osteoinduction (Urist 1965;
Reddi and Huggins 1972; Hagen et al. 1992). The aim of
this study was to evaluate nitrite and nitrate (NO metabo-
lites) levels during ectopic osteoinduction in rats.
Materials and methods
Animals
Eighteen male Sprague–Dawley rats (body weight 200–
300 g) were used in this study. They were maintained in
plastic cages in a room with a 12-h day/night cycle and
an ambient temperature of 21°C, and were allowed ad
libitum access to water and standard laboratory pellets.
Animal selection, management, surgical protocol, and prep-
aration followed the routines approved by the Institutional
Animal Care and Use Committee, Shahrekord University,
Shahrekord, Iran.
Preparation of demineralized bovine fetal bone matrix
A 6-month-old bovine fetus (Holstein) was collected from
the local slaughterhouse. Metacarpal bones were dissected
aseptically, and all soft tissue was removed. The retrieved
bone was then sliced, and demineralization was performed
as described by Reddi and Huggins (1972). The harvested
bone was cleaned of soft tissue and marrow, washed in
sterile distilled water with continuous stirring, then washed
three times in 95% ethanol for 15 min, rinsed in ether for
15 min, and finally air-dried overnight. The cleaned and
dried growth plates were then milled (Universal Mill A-20;
Tekmer Co, Cincinnati, OH, USA) to obtain 400–700-μm
granules and then demineralized in 0.6 NHC1 three times
for 1 h (50 ml HC1/g of bone). The bone powder was
rinsed with several changes of sterile distilled water to
adjust the pH, three times in 95% ethanol and once in ether.
The bone powder was air-dried and stored in sterile plastic
containers at 4°C until required for implantation. This entire
process was performed under sterile conditions (except for
the milling), and a sample was cultured to demonstrate that
specimens contained no bacterial or fungal contamination.
Surgical technique
All animals were anesthetized by means of a subcutaneous
injection of ketamine 100 mg/kg and xylazine 30 mg/kg and
the right and left flank areas were shaved and prepared
aseptically with povidon iodine and draped with sterile
drapes. Under aseptic conditions, a muscular pouch was
created in each flank: the left was filled with 20 mg of DBM
and the right remained empty (sham).
Postoperative evaluation
Radiological evaluation
Radiographs were taken at 2, 4, and 6 weeks after surgery
to trace ectopic bone formation and muscle mineralization.
Assessment of nitrite and nitrate
Blood samples were taken before surgery (as base line
values) and 2, 4, and 6 weeks after surgery. Serum samples
were prepared from rats in each group and stored at −20°C.
Measurement of nitrite and nitrate were based on the
reduction of nitrate to nitrite by cadmium. The nitrite
produced was determined by the Griess reaction. Using this
method, the first serum sample was deproteinized by
adding ZnSO4 (75 mmol/L) and NaOH (55 mmol/L)
solutions. After centrifuging, the supernatant was recovered
and diluted with glycine buffer (45 g/L, pH 9.7). Cadmium
granules (2–2.5 g) were rinsed three times with deionized
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distilled water and swirled in a 5 mmol/L CuSO4 solution
in glycine–NaOH buffer (15 g/L, pH 9.7) for 5 min to
activate them. Freshly activated cadmium granules were
then added to the pretreated deproteinized serum. After
continuous stirring for 10 min, the samples were transferred
to appropriately labeled tubes for nitrite determination by
the Griess reaction. Griess reagent 1 (1% sulfanilamide in
5% phosphoric acid) was added to the sample tubes and
then incubated for 10 min at room temperature, protected
from light. Finally, Griess reagent 2 was dispensed (0.1%
N-napthylethylenediamine dihydrochloride in water) to all
samples, and the absorbance was measured within 10 min
in a spectrophotometer with a 540-nm filter (Navarro-
Gonzalvez et al. 1998).
Statistical analysis
Data were analyzed by one-way analysis of variance and
Duncan test as a post hoc using SPSS 15.0 software.
Results
All surgeries were carried out successfully without any
anesthetic or postoperative complications. Radiological
assessment showed abdominal muscle mineralization and
ectopic new bone formation 6 weeks after the intramuscular
xenogenic DBM implantation (see Fig. 1).
The mean values of NO metabolites after 6 weeks was
significantly (p<0.05) higher than the baseline data and at
2 weeks post-surgery. There were no significant differences
between the NO metabolite levels between the baseline
data and either 2 or 4 weeks after surgery (p>0.05; see
Fig. 2).
Discussion
The process of bone demineralization with hydrochloric acid
decreases antigenic stimulation and may enhance the release
of bone morphogenic protein (BMP; Riley et al. 1996).
BMPs stimulate local undifferentiated mesenchymal cells to
transform into osteoblasts (osteoinduction). These proteins
promote the chondroblastic differentiation of mesenchymal
cells followed by new bone synthesis by endochondral
osteogenesis (Urist 1979, 1983). Our previous study proved
that xenogenic DBM has potential osteoinductive properties
orthotopically (Bigham et al. 2008; Dehghani et al. 2008).
In this study, we also observed ectopic osteoinduction with
intramuscular xenogenic DBM implantation in rats.
In this study, we focused on the levels of NO metabolites
(nitrites and nitrates) during ectopic osteoinduction in rats as
NO has been shown to have significant effects on osteo-
blasts, osteoclasts, and osteocytes. Both eNOS and iNOS
have an important role in the regulation of the proliferation
and function of osteoblasts (Ralston 1994; Hukkanen 1995;
Riancho et al. 1995). It has also been reported that cultured
osteoblasts synthesize NO in response to proinflammatory
cytokines and lipopolysaccaride (Ralston 1994; Damoulis
and Hauschka 1997) and that cytokine-induced NO from
osteoblasts inhibits bone resorption by inducing apoptosis
of osteoclast progenitor cells and suppressing the osteoclast
activity (Yamamoto 1999; Mancini et al. 2000).
In terms of cell proliferation, the NOS inhibitor NG-
monomethyl-L-arginine is reported to induce a dose-
dependent inhibitory effect on the proliferation of
Fig. 1 Radiograph showing abdominal muscle mineralization and
ectopic new bone formation at 6 weeks postoperatively (white arrow)
Fig. 2 Serum levels of NO metabolites (nitrites and nitrates) before and
after surgery (asterisk NO metabolites after 6 weeks was significantly
higher (p<0.05) than baseline and at 2 weeks post-surgery)
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osteoblast-like cell lines MG63 and ROS 17/2.8, which
indicate that NO may stimulate bone cell proliferation
(Riancho et al. 1996). We propose that during the osteo-
induction process local undifferentiated mesenchymal cells
gradually transform into osteoblasts and resulting in a
gradual increase in the levels of NO metabolites. A signif-
icant increase in NO metabolites at 6 weeks postoperatively
suggested optimum activity of the osteoblasts. It is also
reported that NO significantly reduced osteoblast activity at
high concentration, as was evidenced by inhibition of DNA
synthesis, cell proliferation, alkaline phosphatase activity,
and osteocalcin production. Thus, the effect of NO on
osteoblast proliferation is diverse depending on its concen-
tration (Hukkanen 1995; Riancho et al. 1995).
Finally, according to the results of our study, ectopic
osteoinduction caused increasing activity of the osteoblasts
and subsequently caused increased serum levels of NO
metabolites (nitrites and nitrates) due to osteoblastic activity.
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